Cargando…

Defining clinical remission and clinically inactive disease in juvenile systemic lupus erythematosus (jSLE)

Detalles Bibliográficos
Autores principales:	Mina, Rina, Schanberg, Laura, Eberhard, Anne B, Klein–Gitelman, Marisa, Higgins, Gloria, Onel, Karen, Singer, Nora G, O’ Neil, Kathleen, Tucker, Lori, Levy, Deborah, Yousaf, Wajeeha, Nelson, Shannen, Beresford, Michael, Cuttica, Ruben, Espada, Graciela, Ravelli, Angelo, Martini, Alberto, Giannini, Edward, Brunner, Hermine I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194411/ http://dx.doi.org/10.1186/1546-0096-9-S1-O17

Ejemplares similares

Achieving consensus on quality indicators (QI) for pediatric Systemic Lupus Erythematosus (pSLE)
por: Pendl, Joshua, et al.
Publicado: (2011)

Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?—observations from the UK JSLE Cohort Study
por: Smith, Eve M D, et al.
Publicado: (2021)

Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus (jSLE)
por: Natoli, Valentina, et al.
Publicado: (2023)

Lack of association of hepatitis C virus (HCV) antibodies and juvenile onset systemic lupus erythematosus (jSLE)
por: Goldenstein-Schainberg, Cláudia, et al.
Publicado: (2011)

Clinical predictors of proteinuric remission following an LN flare - evidence from the UK JSLE cohort study
por: Smith, Eve M. D., et al.
Publicado: (2018)

Macrophage activation syndrome (MAS) in juvenile systemic lupus erythematosus (JSLE): an underrecognized complication?
por: Parodi, A, et al.
Publicado: (2008)

PReS-FINAL-2291: Activation of TLR pathway JSLE derived neutrophil extracellular traps
por: Thorbinson, C, et al.
Publicado: (2013)

PReS-FINAL-2290: Is an abnormal lipid profile at diagnosis related to increased disease activity in JSLE patients
por: Thorbinson, C, et al.
Publicado: (2013)

From symptom onset to diagnosis: a critical exploration into the experiences of young people with juvenile systemic lupus erythematosus (JSLE)
por: Lloyd, Olivia, et al.
Publicado: (2014)

Simultaneous presentation but contrasting clinical features in 2 female siblings with juvenile systemic lupus erythematosus (JSLE)
por: Janarthanan, Mahesh, et al.
Publicado: (2014)

PReS-FINAL-2303: Exploring potential differences in demographics, family history and disease characteristics in JSLE patients with different age of onset
por: Groot, N, et al.
Publicado: (2013)

14.2 Causes of early death in juvenile onset systemic lupus erythematosus (JSLE)
por: Bader-Meunier, B, et al.
Publicado: (2008)

PReS-FINAL-2301: Cardiac tamponade and auto-immune haemolysis as first presentation of JSLE
por: Yiallourides, M, et al.
Publicado: (2013)

Retrospective study of juvenile systemic lupus erythematosus (JSLE) over the last 20 years: single center experience
por: Tambic Bukovac, L, et al.
Publicado: (2008)

Developing consensus treatment plans for proliferative lupus nephritis in childhood-onset systemic lupus erythematous
por: Mina, Rina, et al.
Publicado: (2012)

Clinical comparisons between previously diagnosed SLE and newly diagnosed SLE by kidney biopsy
por: Tonsawan, Pantipa, et al.
Publicado: (2020)

Elevated serum complement levels and higher gene copy number of complement C4B are associated with hypertension and effective response to statin therapy in childhood-onset systemic lupus erythematosus (SLE)
por: Mulvihill, Evan, et al.
Publicado: (2019)

Immune Complex Signatures of Patients with Active and Inactive SLE Revealed by Multiplex Protein Binding Analysis on Antigen Microarrays
por: Papp, Krisztián, et al.
Publicado: (2012)

Clinical impact of biologic therapy in the treatment of SLE
por: Wallace, Daniel J
Publicado: (2013)

Comparison of bone mass and quality determinants in adolescents and young adults with juvenile systemic lupus erythematosus (JSLE) and juvenile idiopathic arthritis (JIA)
por: Falcini, Fernanda, et al.
Publicado: (2014)

PReS-FINAL-2174: The performance of the new slicc criteria for the classification of sle in children
por: Sag, E, et al.
Publicado: (2013)

Progression of subclinical and clinical cardiovascular disease in a UK SLE cohort: the role of classic and SLE-related factors
por: Haque, Sahena, et al.
Publicado: (2018)

MHC associations with clinical and autoantibody manifestations in European SLE
por: Morris, DL, et al.
Publicado: (2014)

Engaging African ancestry participants in SLE clinical trials
por: Anjorin, Aderike, et al.
Publicado: (2018)

Treatment patterns in paediatric and adult patients with SLE: a retrospective claims database study in the USA
por: Brunner, Hermine I, et al.
Publicado: (2023)

Differences in disease phenotype and severity in SLE across age groups
por: Ambrose, N, et al.
Publicado: (2016)

Usefulness of the lupus low disease activity state as a treatment target in childhood-onset SLE
por: Cody, Ellen M, et al.
Publicado: (2023)

Duration biased distribution of clinical and immunological phenotypes in active SLE
por: Yan, Qingran, et al.
Publicado: (2022)

Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis
por: Romick-Rosendale, Lindsey E, et al.
Publicado: (2011)

Pediatric Rheumatology Collaborative Study Group – over four decades of pivotal clinical drug research in pediatric rheumatology
por: Brunner, Hermine I., et al.
Publicado: (2018)

Treatment of SLE: bridging the gap from clinical trials to the clinic - a meeting report
por: Calabrese, Leonard H
Publicado: (2013)

SLE and APS
por: Avcin, Tadej
Publicado: (2014)

Epigenetics in SLE
por: Hedrich, Christian Michael
Publicado: (2017)

Biologic excipients: Importance of clinical awareness of inactive ingredients
por: Ionova, Yelena, et al.
Publicado: (2020)

Quality of life and satisfaction with life in SLE patients—the importance of clinical manifestations
por: Kulczycka, Lilianna, et al.
Publicado: (2010)

SLE clinical trials: impact of missing data on estimating treatment effects
por: Kim, Mimi, et al.
Publicado: (2019)

Analysis of transcriptomic features reveals molecular endotypes of SLE with clinical implications
por: Hubbard, Erika L., et al.
Publicado: (2023)

Uncoupling interferons and the interferon signature explain clinical and transcriptional subsets in SLE
por: Gómez-Bañuelos, Eduardo, et al.
Publicado: (2023)

MicroRNA's role as biomarkers of lupus nephritis in children
por: Abulaban, Khalid, et al.
Publicado: (2014)

Update on differences between childhood-onset and adult-onset systemic lupus erythematosus
por: Mina, Rina, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_e02ftro4g2742gmu527d5a3o1d